Tags: Chemical Compound, Chemical Substance.

Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS).Laquinimod is the successor of Active Biotech’s failed experimental immunomodulator linomide.The compound has been investigated in two Phase II trials using successive magnetic resonance scans (MRI). Laquinimod seems to be able to reduce the MS disease activity on MRI.

Laquinimod.svg
IUPAC name
5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-, N-phenyl-12-dihydroquinoline-3-carboxamide

Loading...

This page contains content from the copyrighted Wikipedia article "Laquinimod"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.